Oncology and Hematology
Episodes 33-48 of 127
Peter Schmid, FRCP, MD, PhD
- MinuteCE®
Adjuvant Treatments for HR+/HER2- EBC: The Role of CDK4/6 and PARP Inhibitors
1.50 program creditsErica L. Mayer, MD, MPH
Peter Schmid, FRCP, MD, PhD
Erica L. Mayer, MD, MPH
Aparna R. Parikh, MD
Ritu Salani, MD, MBA
Susana Campos, MD, MPH
- MinuteCE®
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
1.00 program creditRitu Salani, MD, MBA
Nicoletta Colombo, MD
Ignacio Duran, MD
Wenxin Xu, MD
Ignacio Duran, MD
Wenxin Xu, MD
- MinuteCE®
Emerging immunotherapy combination strategies in genitourinary malignancies
1.25 program creditsSandy Srinivas, MD
- MinuteCE®
Guideline Updates for ADT: Best Practices for Treating Advanced Prostate Cancer
0.75 program creditsTanya Dorff, MD
Susana Campos, MD, MPH
Nicoletta Colombo, MD
Ritu Salani, MD, MBA
Nicoletta Colombo, MD
- MinuteCE®
First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
1.00 program creditNicoletta Colombo, MD
Ritu Salani, MD, MBA
